Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Concord Biotech Ltd. Share Price
Day's Range
Day's Range
Low
₹1,112.70
High
₹1,149.40
Price Summary
| Previous Close | ₹1,135.30 |
|---|---|
| Day's Range | ₹1,112.70 - ₹1,149.40 |
| Open | ₹1,140.00 |
| 52 Week Range | ₹987.00 - ₹2,150.40 |
| Volume | 67,969 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 770.56 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.94 |
| Price/Earning (TTM) | 37.98 |
| TTM EPS (₹) | 29.87 |
| P/E Ratio | 47.19 |
| Book Value(₹) | 6.27 |
| PAT Margin (%) | 30.97 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 29.62 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 2442.2 | 10169.39 |
| Expenses | N/A | N/A |
| PBT | 1011.52 | 4125.64 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 759.21 | 3081.03 |
About Concord Biotech Ltd.
| Founded | 1984 |
|---|---|
| Managing Director | Sudhir Vaid |
| NSE Symbol | CONCORDBIO |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,074.97 | 1,879.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,485.96 | 6,755.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,124.14 | 4,386.00 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,201.01 | 8,077.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,640.69 | 1,431.55 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,589.46 | 1,336.95 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,966.32 | 2,273.90 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,03,368.09 | 2,507.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,02,190.60 | 1,050.05 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,01,755.41 | 1,011.25 | 835.50 - 835.50 |
No Records Found
Latest News
Concord Biotech informs about investor conference
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Concord Biotech has informed that the officials of the Company will be attending the Investor Conference on 26th February 2026 at 9:00 am onwards in Mumbai Organised by Kotak Institutional Equities (1x1 / Group Meeting). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
Concord Biotech informs about investor conference
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Concord Biotech has informed that the officials of the Company will be attending the Investor Conference on 25th February 2026 at 11:00 am onwards in Mumbai Organised by IIFL Capital (1x1 / Group Meeting). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
Krishna Institute of Medical Sciences informs about investor presentation
Onesource Specialty Pharma informs about updates
Acutaas Chemicals informs about corporate presentation
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Concord Biotech Ltd. is ₹1,135.30 as of 2026-05-15.
The market capitalisation of Concord Biotech Ltd. is ₹11,870.28 as of 2026-05-15.
The 1-year return of Concord Biotech Ltd. is 0.00% as of 2026-05-15.
The P/E ratio of Concord Biotech Ltd. is 47.19 as of 2026-05-16.
The 52-week high and low of Concord Biotech Ltd. are ₹2,150.40 and ₹987.00, respectively, as of 2026-05-15.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
